Wyeth Pharmaceuticals Inc is seeking $960 million in damages from Sun Pharmaceutical Industries for alleged patent infringement in launching a generic version of acid reflux drug Protonix in the United
BSE-listed Sun Pharmaceutical Industries got a reprieve from a US court as Pfizer-controlled Wyeth’s complaint on Protonix, an anti-ulcer drug, was thrown out. The US district court for the eastern
Stay informed on our latest news!